Article
Genome-first determination of the prevalence and penetrance of eight germline myeloid malignancy predisposition genes: a study of two population-based cohorts.
Leukemia - 1 Feb 2025
Hendricks Rachel M, Kim Jung, Haley Jeremy S, Ramos Mark Louie, Mirshahi Uyenlinh L, Carey David J, Stewart Douglas R, McReynolds Lisa J
Abstract excerpt
It is estimated that 10% of individuals with a myeloid malignancy carry a germline susceptibility. Using the genome-first approach, in which individuals were ascertained on genotype alone, rather than clinical phenotype, we quantified the prevalence and penetrance of pathogenic germline variants in eight myeloid malignancy predisposition (gMMP) genes. ANKRD26, CEBPA, DDX41, MECOM, SRP72, ETV6, RUNX1 and GATA2,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
